Evidence map›Paper›PMID 20139184›Full record

ArticleJournal of bacteriology2010

Role of the DinB homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis.

Bavesh D Kana, Garth L Abrahams, Nackmoon Sung, Digby F Warner, Bhavna G Gordhan, Edith E Machowski, Liana Tsenova, James C Sacchettini, Neil G Stoker, Gilla Kaplan and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evolution ofFrontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Transcriptional Response ofFrontiers in microbiology · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Ribonucleotide discrimination by translesion synthesis DNA polymerases.Critical reviews in biochemistry and molecular biology · 2018
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Bavesh D KanaMRC/NHLS/WITS Molecular Mycobacteriology Research Unit, DST/NRF Centre of Excellence for Biomedical TB Research, School of Pathology of the University of the Witwatersrand and the National Health Laboratory Service, Johannesburg, South Africa. bavesh.kana@nhls.ac.za
Garth L Abrahams
Nackmoon Sung
Digby F Warner
Bhavna G Gordhan
Edith E Machowski
Liana Tsenova
James C Sacchettini
Neil G Stoker
Gilla Kaplan
Valerie Mizrahi
National Health Laboratory Service · ZAInternational Center for Public Health · USUniversity of the Witwatersrand · ZARoyal Veterinary College · GBTexas A&M University · US

Funding

TUBERCULOSIS SUPPLEMENTD43TW000231 · FIC · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ABDOOL KARIM, QUARRAISHA · 1993 to 2014
$13.1M
Host &Pathogen Determinants of M tuberculosis LatencyR01AI054338 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KAPLAN, GILLA · 2002 to 2011
$5.0M
FIC NIH HHS D43 TW000231FIC NIH HHS D43 TW00231Howard Hughes Medical InstituteNIAID NIH HHS R01 AI054338NIAID NIH HHS R01 AI 54338Wellcome Trust
6 · The paper itself

Abstract

The environment encountered by Mycobacterium tuberculosis during infection is genotoxic. Most bacteria tolerate DNA damage by engaging specialized DNA polymerases that catalyze translesion synthesis (TLS) across sites of damage. M. tuberculosis possesses two putative members of the DinB class of Y-family DNA polymerases, DinB1 (Rv1537) and DinB2 (Rv3056); however, their role in damage tolerance, mutagenesis, and survival is unknown. Here, both dinB1 and dinB2 are shown to be expressed in vitro in a growth phase-dependent manner, with dinB2 levels 12- to 40-fold higher than those of dinB1. Yeast two-hybrid analyses revealed that DinB1, but not DinB2, interacts with the beta-clamp, consistent with its canonical C-terminal beta-binding motif. However, knockout of dinB1, dinB2, or both had no effect on the susceptibility of M. tuberculosis to compounds that form N(2)-dG adducts and alkylating agents. Similarly, deletion of these genes individually or in combination did not affect the rate of spontaneous mutation to rifampin resistance or the spectrum of resistance-conferring rpoB mutations and had no impact on growth or survival in human or mouse macrophages or in mice. Moreover, neither gene conferred a mutator phenotype when expressed ectopically in Mycobacterium smegmatis. The lack of the effect of altering the complements or expression levels of dinB1 and/or dinB2 under conditions predicted to be phenotypically revealing suggests that the DinB homologs from M. tuberculosis do not behave like their counterparts from other organisms.

Indexed as

4-Nitroquinoline-1-oxideAcroleinAnimalsBacterial ProteinsBenzopyrenesCells, CulturedFemaleHumansMacrophagesMiceMicrobial Sensitivity TestsMycobacterium tuberculosisNitrofurazoneProtein BindingQuinolonesReverse Transcriptase Polymerase Chain Reaction4-Nitroquinoline-1-oxide4-nitroquinolone-1-oxideAcroleinBacterial ProteinsBenzopyrenesNitrofurazoneQuinolones

Identifiers

PMID20139184
PMCPMC2849458
OpenAlexW2121823715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.